All stock lists
Achieve Life Sciences, Inc. (NASDAQ:ACHV)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.56+0.07 (+1.08%)
Insider Score
––Not scored
ACHV Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ACHV Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 57.00 K | 0.00 | 54.00 K | 0.00 | 0.00 |
| Gross Profit | 0.00 | -57.00 K | 0.00 | -54.00 K | 0.00 | 0.00 |
| SG&A Expense | 14.58 M | 7.11 M | 10.86 M | 9.37 M | 5.86 M | 5.80 M |
| R&D Expense | 3.81 M | 3.29 M | 3.87 M | 5.32 M | 6.71 M | 7.10 M |
| Operating Expenses | 18.39 M | 10.41 M | 14.73 M | 14.64 M | 12.56 M | 12.89 M |
| Operating Income | -18.39 M | -10.46 M | -14.73 M | -14.69 M | -12.56 M | -12.89 M |
| Pretax Income | -74.77 M | -10.17 M | -14.66 M | -14.44 M | -12.72 M | -12.83 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -74.77 M | -10.17 M | -14.66 M | -14.44 M | -12.72 M | -12.83 M |
| EPS (Basic) | -0.80 | -0.19 | -0.28 | -0.28 | -0.37 | -0.37 |
| EPS (Diluted) | -0.80 | -0.19 | -0.28 | -0.28 | -0.37 | -0.37 |
| Shares Outstanding | 93.51 M | 53.38 M | 53.28 M | 51.02 M | 34.69 M | 34.69 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.